Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
---|---|---|---|---|---|---|---|---|
2024-01-16 | Mirati Therapeutics, Inc. | Hickey Benjamin
(EVP, Chief Commercial Officer) |
S | Common Stock | D | 1597 | $59.02 - $59.02 | $94,254 |
2024-01-16 | Mirati Therapeutics, Inc. | Christensen Jamie
(EVP & Chief Scientific Officer) |
S | Common Stock | D | 1597 | $59.02 - $59.02 | $94,254 |
2024-01-08 | Mirati Therapeutics, Inc. | Hickey Benjamin
(EVP, Chief Commercial Officer) |
S | Common Stock | D | 2090 | $58.92 - $58.92 | $123,142 |
2023-12-29 | Mirati Therapeutics, Inc. | Sharp Shalini
(Director) |
A | Common Stock | A | 6808 | $58.75 - $58.75 | $399,970 |
2023-12-18 | Mirati Therapeutics, Inc. | Christensen Jamie
(EVP & Chief Scientific Officer) |
S | Common Stock | D | 2387 | $57.50 - $57.50 | $137,252 |
2023-12-13 | Mirati Therapeutics, Inc. | Hickey Benjamin
(EVP, Chief Commercial Officer) |
S | Common Stock | D | 2220 | $56.67 - $56.67 | $125,807 |
A | Grant, award or other acquisition |
C | Conversion of Derivative or Security |
D | Disposition to the issuer of issuer equity securities |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability |
G | Bona fide Gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary Transaction |
J | Other acquisition or disposition |
K | Transaction in equity swap or instrument with similar characteristics |
L | Small Acquisition |
M | Exercise or conversion of derivative security |
O | Exercise of out-of-the-money derivative security |
P | Open Market Purchase |
S | Open Market Sale |
U | Disposition pursuant to a tender of shares in a change of control transaction |
V | Transaction Voluntarily Reported |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |